![Claudio Soto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Claudio Soto
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Amprion, Inc.
![]() Amprion, Inc. Medical SpecialtiesHealth Technology Amprion, Inc. is a company based in San Diego, CA that specializes in biomarker testing for brain diseases. The American company's Syntap® biomarker test aids physicians in the clinical diagnosis of Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The test identifies misfolded synuclein aggregates, a hallmark in various neurodegenerative diseases. Amprion plans to launch other biomarker tests to detect Alzheimer's in early stages. The company was founded in 2006 by Claudio Soto and Russ M. Lebovitz, who has been the CEO since then. | Hoofd Techniek/Wetenschap/O&O | - | - |
Oprichter | - | - |
Loopbaan van Claudio Soto
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Amprion, Inc.
![]() Amprion, Inc. Medical SpecialtiesHealth Technology Amprion, Inc. is a company based in San Diego, CA that specializes in biomarker testing for brain diseases. The American company's Syntap® biomarker test aids physicians in the clinical diagnosis of Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The test identifies misfolded synuclein aggregates, a hallmark in various neurodegenerative diseases. Amprion plans to launch other biomarker tests to detect Alzheimer's in early stages. The company was founded in 2006 by Claudio Soto and Russ M. Lebovitz, who has been the CEO since then. | Health Technology |
- Beurs
- Insiders
- Claudio Soto
- Ervaring